Cargando…
A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States
COVID-19 vaccines were first administered on 15 December 2020, marking an important transition point for the spread of SARS-CoV-2 in the United States (U.S.). Prior to this point in time, the virus spread to an almost completely immunologically naïve population, whereas subsequently, vaccine-induced...
Autores principales: | Capoferri, Adam A., Shao, Wei, Spindler, Jon, Coffin, John M., Rausch, Jason W., Kearney, Mary F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778900/ https://www.ncbi.nlm.nih.gov/pubmed/35062308 http://dx.doi.org/10.3390/v14010104 |
Ejemplares similares
-
2020 SARS-CoV-2 diversification in the United States: Establishing a pre-vaccination baseline
por: Capoferri, Adam A., et al.
Publicado: (2021) -
Low genetic diversity may be an Achilles heel of SARS-CoV-2
por: Rausch, Jason W., et al.
Publicado: (2020) -
Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults
por: Kearney, Mary F., et al.
Publicado: (2018) -
Coordinating SARS-CoV-2 genomic surveillance in the United States
por: Nelson, Martha I, et al.
Publicado: (2021) -
Genomic surveillance of SARS-CoV-2 in the state of Delaware reveals tremendous genomic diversity
por: Franke, Karl R., et al.
Publicado: (2022)